(324 days)
Not Found
No
The description focuses on standard sensor-based control of temperature and humidity, without mentioning any AI/ML algorithms for prediction, optimization, or complex pattern recognition. The "Mentions AI, DNN, or ML" section explicitly states "Not Found".
No
The device is an infant incubator for providing a warm environment and controlled air to premature or neonatal infants. While it supports vital functions, it does not treat or cure a disease or condition, which is characteristic of a therapeutic device.
No
Explanation: The device is an infant incubator designed to provide a warm and controlled environment for neonates. While it monitors vital signs like skin temperature, humidity, and SpO2, its primary function is therapeutic (maintaining physiological conditions) rather than diagnostic (identifying or characterizing a disease or condition). The information gathered is for monitoring and controlling the environment, not for diagnosing medical conditions.
No
The device description explicitly lists hardware components such as a Hood, Control Box, LCD external monitor, main body with stand, sensors, and a heater. This indicates it is a physical medical device with integrated software, not a software-only device.
Based on the provided information, the Bisto's BT-500 Infant Incubator is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use is to provide a controlled warm environment for premature and neonatal infants to prevent hypothermia, and for observation and examination. This is a life support and environmental control function, not a diagnostic test performed on samples taken from the body.
- Device Description: The device description focuses on controlling temperature, humidity, and air circulation, and monitoring physiological parameters like skin temperature, weight, and SpO2. These are measurements of the infant's physical state, not analyses of biological samples.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), reagents, or performing diagnostic tests to identify diseases or conditions.
In summary, the BT-500 is a medical device designed to provide a supportive environment for infants, not to perform diagnostic testing on biological samples.
N/A
Intended Use / Indications for Use
Bisto's BT-500 is a Infant Incubator and intended to keep Premature in a warm environment in the hood for Neonatal hypothermia, Observation and Examination in newborn nurseries.
BT-500 provides Heat and Air in a controlled manner to neonates or premature infants who are unable to themn-regulate on their own physiology.
BT-500 is not intended for transport.
Product codes
FMZ
Device Description
BT-500 Infant Incubator consists of Hood, Control Box, LCD external monitor and main body with stand ( optional), This device incorporates two sensors to control Humidity, and Temperature inside the Hood and monitors the Air Conditions, and controls Circulation with proper temperature.
Also Heater is equipped inside of the hood to control the Skin Temperature of Infant at a fixed level as measured by the skin probe and showing, measuring and graphing the humidity, Air Temperature, Skin Temperature, Weight and SpO2
This Incubator is provided with function to control the infant's skin temperature.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Neonates, Premature infants
Intended User / Care Setting
newborn nurseries.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
BT-500 Infant Incubator done various Performing, Safety test voluntary and accordance with the guidance for Industry and FDA Staff - Neonatal Transport Incubator Premarket notifications., and all test report attached
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5400 Neonatal incubator.
(a)
Identification. A neonatal incubator is a device consisting of a rigid boxlike enclosure in which an infant may be kept in a controlled environment for medical care. The device may include an AC-powered heater, a fan to circulate the warmed air, a container for water to add humidity, a control valve through which oxygen may be added, and access ports for nursing care.(b)
Classification. Class II (performance standards).
0
BT-500 Infant Incubator
Summary of safety and effectiveness K132543
In accordance with section 513(1) of the SMDA as defined in 21CFR part 807.92 This summary is submitted to obtain Pre-Market 510(K) notification.
1. Submitter, Manufacturer
Prepared on Sept 20,2013
Bistos Co,. Ltd. Reg Number 3006179052 7th fl, WooRim Lions Valley 5, 144-3 SangDae Won, JungWon Gu, SeoungNam, GyeongGi Do, Republic of Korea T: 31 750 0340 F: 31 750 0344
- Preparer / Contact person. Mr. Young Chi, President. Bio-Med USA Inc. 27 New England Drive, Ramsey, NJ 07446. USA T: 973 278 5222 F: 201 934 6030 e mail: biomedusa@msn.com
3. Name of Device.
: BT-500 Infant Incubator Trade Name Common or usual name : Neonatal Incubator Regulation number/class : 880.5400 / II Product Code : FMZ Classification panel : General Hospital
- Substantial Equivalence
K102710 Atom Infant incubator model 102, Atom Medical Inc
Bistos BT-500 infant incubator is substantially equivalent in Intended Use, Design, Function, Performing, Direction to use, software, Technology etc to Predicate device.
5. Device Description.
BT-500 Infant Incubator consists of Hood, Control Box, LCD external monitor and main body with stand ( optional), This device incorporates two sensors to control Humidity, and Temperature inside the Hood and monitors the Air Conditions, and controls Circulation with proper temperature.
Also Heater is equipped inside of the hood to control the Skin Temperature of Infant at a fixed level as measured by the skin probe and showing, measuring and graphing the humidity, Air Temperature, Skin Temperature, Weight and SpO2
This Incubator is provided with function to control the infant's skin temperature.
1
6. Intended use.
Bistos' BT-500 is a Infant Incubator and intended to keep Premature Neonate infants in a warm environment in the hood for Neonatal hypothermia, Observation and Examination in newborn nurseries.
BT-500 provides Heat and Air in a controlled manner to neonates or premature infants who are unable to thermo- requlate on their own physiology.
BT-500 is not intended for transport.
7 Labeling
Back label, Market promoting leaflet designed by labeling requirement regulation under (21CFR part 801) is on Technical Construction File.
8.Biocompatibility test.
BT-500 used same material of patient contacted part as already cleared Neo-Servo under K102710, and done Biocompatibility test by NAMSA ( North American Science ) by FDA guidance Blue Book Memo G95-1 use of ISO 10993 Biological Evaluation of Medical Device part 4, 5, 10.
9. Test Data
BT-500 Infant Incubator done various Performing, Safety test voluntary and accordance with the guidance for Industry and FDA Staff -Neonatal Transport Incubator Premarket notifications., and all test report attached
10, Conclusion.
BT-500 Infant Incubator is substantially equivalent in Intended use Design, Function, Performing, direction to use, software, Technology/Principle of operation as already cleared predicate device K102710 model 102.
So, BT-500 Infant Incubator has no new issues in safety and effectiveness. End of Summarv
2
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
July 3, 2014
Bistos Company, Limited C/O Mr. Young Chi Bio-Med USA, Incorporated 27 New England Drive Ramsey, New Jersey 07446
Re: K132543
Trade/Device Name: BT-500 Infant Incubator Regulation Number: 21 CFR 880.5400 Regulation Name: Neonatal incubator Regulatory Class: Class II Product Code: FMZ Dated: June 24, 2014 Received: June 26, 2014
Dear Mr. Chi:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or 10 devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Mr. Chi
Please be advised that FDA 's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Mary S. Runner -S
Erin Keith, M.S. Division Director Division of Anesthesiology, General Hospital. Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known) K132543
Device Name BT-500 Infant Incubator
Indications for Use (Describe)
Bisto's BT-500 is a Infant Incubator and intended to keep Premature in a warm environment in the hood for Neonatal hypothermia, Observation and Examination in newborn nurseries.
BT-500 provides Heat and Air in a controlled manner to neonates or premature infants who are unable to themn-regulate on their own physiology.
BT-500 is not intended for transport.
Type of Use (Select one or both, as applicable)
2 Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
: . .
Digitally signed by Richard C. Chapman -S Date: 2014.07.03 11:54:25 -04'00'
This section applies only to requirements of the Paperwork Reduction Act of 1995.
*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW."
The burden time for this collection of information is estimated to average 79 hours per response, Including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.